NeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting - Allele Capital

https://ir.neubasetherapeutics.com/news-events/press-releases/detail/88/neubase-therapeutics-selected-to-present-two-oral